The company is collaborating on multiple vaccine localization production projects with several countries, including Morocco and Indonesia.
January 3, 2025
Source: drugdu
226
According to a report by Daily Economic News, an investor asked on the investor interaction platform: During research inquiries, the company responded that through diversified methods such as technology and equity cooperation, while controlling core cutting-edge technologies, they are helping localities establish independent vaccine production capabilities! Is the company planning to establish joint ventures with foreign partners on-site? Is Watson providing the technology while locals provide the funding?
Watson Bio (300142.SZ) stated on the investor interaction platform on December 31 that the company is indeed collaborating on multiple vaccine localization production projects with countries like Morocco and Indonesia. For matters related to the company's equity cooperation or other significant issues, please refer to the company's official announcements.
https://finance.eastmoney.com/a/202412313283825090.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- The United States may impose tariffs on drug imports. Many pharmaceutical companies responded with “close attention” April 11, 2025
- The United States will impose tariffs on drugs April 11, 2025
- Zhifei Biotech’s bivalent dysentery vaccine is ready to start enrolling subjects April 11, 2025
- The oral vaccine developed by Kangtai Biological and its subsidiaries has started Phase III clinical trials April 11, 2025
- Career Development Guide for API and Pharmaceutical Intermediate Sales Professionals April 8, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
